MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 596300 | Name: JTH-601 free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

JTH-601 free base is an alpha 1 adenergic recepor anagonist.

Chemical Structure

JTH-601 free base
JTH-601 free base
CAS#171277-06-8

Theoretical Analysis

MedKoo Cat#: 596300

Name: JTH-601 free base

CAS#: 171277-06-8

Chemical Formula: C24H35NO4

Exact Mass: 401.2566

Molecular Weight: 401.54

Elemental Analysis: C, 71.79; H, 8.79; N, 3.49; O, 15.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
JTH-601; JTH-601 free base;
IUPAC/Chemical Name
3-(((2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl)(methyl)amino)methyl)-4-methoxy-2,5,6-trimethylphenol
InChi Key
VXLRYJNESHCVDX-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H35NO4/c1-14(2)19-12-21(26)15(3)11-22(19)29-10-9-25(7)13-20-18(6)23(27)16(4)17(5)24(20)28-8/h11-12,14,26-27H,9-10,13H2,1-8H3
SMILES Code
OC1=C(C)C(C)=C(OC)C(CN(CCOC2=CC(C)=C(O)C=C2C(C)C)C)=C1C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 401.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Nobata K, Fujimura M, Ishiura Y, Hirose T, Furusyou S, Myou S, Kurashima K, Kasahara K, Nakao S. Alpha(1L)-, but not alpha(1H)-, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo. Eur J Pharmacol. 2002 Sep 27;452(1):97-104. PubMed PMID: 12323390. 2: Hirai T, Tsuru H, Tanimitsu N, Yajin K, Sasa M. Effect of JTH-601, a putative alpha(1L)-adrenoceptor antagonist, on guinea pig nasal mucosa vasculature. Eur J Pharmacol. 2001 Mar 23;416(1-2):141-4. PubMed PMID: 11282123. 3: Qiao X, Norota I, Endoh M. Pharmacological characteristics of inhibitory action of the selective alpha1-antagonist JTH-601 on the positive inotropic effect mediated by alpha1-adrenoceptors in isolated rabbit papillary muscle. Jpn J Pharmacol. 2000 Nov;84(3):301-9. PubMed PMID: 11138731. 4: Yamada S, Okura T, Kimura R, Deguchi Y, Suzuki Y, Kobayashi T, Aisaka K. Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues. Drug Metab Dispos. 2000 Dec;28(12):1487-92. PubMed PMID: 11095588. 5: Takahashi M, Taniguchi T, Kanamaru H, Okada K, Muramatsu I. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates. Life Sci. 2000 Oct 6;67(20):2443-51. PubMed PMID: 11065167. 6: Suzuki Y, Moriyama N, Okaya Y, Kanada A, Nishimatsu H, Kawabe K, Aisaka K. Distribution of alpha1L-adrenoceptors in canine prostate: characterization by quantitative autoradiography. J Pharm Pharmacol. 2000 Jun;52(6):653-7. PubMed PMID: 10875541. 7: Suzuki Y, Kanada A, Okaya Y, Aisaka K. Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on prostate function in dogs. Eur J Pharmacol. 2000 Apr 7;394(1):123-30. PubMed PMID: 10771044. 8: Suzuki Y, Kanada A, Okaya Y, Kurahashi Y, Kogayu M, Kobayashi T, Aisaka K. Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs. BJU Int. 2000 Mar;85(4):542-50. PubMed PMID: 10691841. 9: Suzuki Y, Moriyama N, Kanada A, Okaya Y, Kawabe K, Aisaka K. The role of alpha 1L-adrenoceptor in rat urinary bladder: comparison between young adult and aged rats. Life Sci. 1999;65(24):2553-9. PubMed PMID: 10619363. 10: Suzuki Y, Moriyama N, Okaya Y, Nishimatsu H, Kawabe K, Aisaka K. Age-related change of the role of alpha1L-adrenoceptor in canine urethral smooth muscle. Gen Pharmacol. 1999 Oct;33(4):347-54. PubMed PMID: 10523074. 11: Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol. 1999 Jul;127(6):1367-74. PubMed PMID: 10455286; PubMed Central PMCID: PMC1760646. 12: Ohkura T, Yamada S, Tohma A, Kimura R, Aisaka K. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues. Biol Pharm Bull. 1999 Jul;22(7):687-90. PubMed PMID: 10443463. 13: Suzuki Y, Kanada A, Okaya Y, Aisaka K, Muramatsu I. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure. Eur J Pharmacol. 1999 Jun 25;374(3):495-502. PubMed PMID: 10422795. 14: Stam WB, Van der Graaf PH, Saxena PR. Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol. 1999 Jun;127(3):661-70. PubMed PMID: 10401556; PubMed Central PMCID: PMC1566064. 15: Takahashi M, Taniguchi T, Murata S, Okada K, Moriyama N, Yamazaki S, Muramatsu I. New alpha1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries. J Urol. 1999 Apr;161(4):1350-4. PubMed PMID: 10081906. 16: Kawabe K. Current status of research on prostate-selective alpha 1-antagonists. Br J Urol. 1998 Mar;81 Suppl 1:48-50. Review. PubMed PMID: 9589017. 17: Yamada S, Ohkura T, Kimura R, Kawabe K. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia. Life Sci. 1998;62(17-18):1585-9. PubMed PMID: 9585140. 18: Muramatsu I, Takita M, Suzuki F, Miyamoto S, Sakamoto S, Ohmura T. Subtype selectivity of a new alpha 1-adrenoceptor antagonist, JTH-601: comparison with prazosin. Eur J Pharmacol. 1996 Apr 4;300(1-2):155-7. PubMed PMID: 8741183.